Tanya Lewis - 01 Jun 2025 Form 4 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Scott Kellen, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
01 Jun 2025
Net transactions value
$0
Form type
4
Filing time
03 Jun 2025, 16:17:10 UTC
Previous filing
03 Jun 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lewis Tanya Director 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS /s/ Scott Kellen, attorney-in-fact 03 Jun 2025 0001451038

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding DMAC Voting Common Shares, no par value per share 0 01 Jun 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DMAC Stock Option (right to buy) Award $0 +32,162 $0.000000 32,162 01 Jun 2025 Common Shares 32,162 $4.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in four nearly equal quarterly installments over one year.